• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
  • For Subscribers

Suzi Ring

Stay informed with Suzi Ring’s coverage and analysis.

Sanofi and GSK to restart trial of COVID-19 vaccine after delay
Health
Sanofi and GSK to restart trial of COVID-19 vaccine after delay
By Tim Loh, Suzi Ring and BloombergFebruary 22, 2021
University of Oxford to begin testing AstraZeneca vaccine on children
Health
University of Oxford to begin testing AstraZeneca vaccine on children
By Suzi Ring and BloombergFebruary 15, 2021
Britons will roll up their sleeves on Tuesday for a COVID vaccine jab as the world anxiously watches
Health
Britons will roll up their sleeves on Tuesday for a COVID vaccine jab as the world anxiously watches
By James Paton, Suzi Ring and BloombergDecember 7, 2020
Syringe shown against the AstraZeneca logo
Health
AstraZeneca eyes another global trial for its COVID vaccine following dosage blip
By Suzi Ring, James Paton and BloombergNovember 27, 2020
Oxford says COVID-19 vaccine has produced strong immune response ahead of late-stage trial results
Health
Oxford says COVID-19 vaccine has produced strong immune response ahead of late-stage trial results
By James Paton, Suzi Ring and BloombergNovember 19, 2020
AstraZeneca-Oxford COVID vaccine on track for year end, CEO Pascal Soriot says
Health
AstraZeneca-Oxford COVID vaccine on track for year end, CEO Pascal Soriot says
By Suzi Ring, James Paton and BloombergNovember 5, 2020
Sanofi will combine its experimental coronavirus vaccine with GlaxoSmithKline Plc’s adjuvant technology, which may allow more doses of a shot to be produced.
Health
Sanofi and GlaxoSmithKline are teaming up to develop a coronavirus vaccine
By James Paton, Suzi Ring and BloombergApril 14, 2020
1
  • 1
  • 2
2
Most Popular
AI
The Trump White House is starting to admit that your bank account and airline tickets are under attack from rogue AIplaceholder alt text
By Nick LichtenbergNovember 17, 2026
Commentary
If it looks like a DDoS attackplaceholder alt text
By Matthew AndrianiNovember 17, 2026
Health
The man who sold Aetna to CVS for almost $70 billion says the deal was cover for problems ‘they never really fixed’—just as CVS breaks itself in twoplaceholder alt text
By Nick LichtenbergNovember 17, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • TikTok icon
  • YouTube icon

    © 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
    FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.